TABLE 4.
Spearman correlations between serologies, cytokines and lipid profile in the ICU patients
| Anti‐S1 IgG r; P‐value | Anti‐N total ab r; P‐value | Anti‐apoA‐1 IgG r; P‐value | |
|---|---|---|---|
| Serologies | |||
| Anti‐S1 IgG; ratio | ND | 0.77; <.0001 | 0.43; <.0001 |
| Anti‐N total ab; ratio | 0.77; <.0001 | ND | 0.44; <.0001 |
| Anti‐apoA‐1 IgG, OD450 | 0.43; <.0001 | 0.44; <.0001 | ND |
| Cytokines | |||
| CRP; mg/L | 0.18; .05 | 0.16; .08 | 0.20; .02 |
| IFN‐γ, pg/mL | −0.25; .005 | −0.25; .005 | −0.19; .04 |
| IL‐6, pg/mL | −0.02; .81 | −0.07; .47 | 0.11; .24 |
| TNF‐α, pg/mL | −0.02; .83 | −0.09; .32 | 0.12; .19 |
| MCP‐1, pg/mL | 0.04; .69 | 0.006; .94 | 0.01; .93 |
| IFN‐α2a, pg/mL | −0.36; .0003 | −0.44; <.0001 | −0.30; .0005 |
| D‐dimers; ng/mL | 0.29; .004 | 0.11; .26 | 0.05; .63 |
| Lipid profile | |||
| Total cholesterol, mmol/L | 0.12; .21 | 0.04; .70 | −0.16; .06 |
| HDL cholesterol, mmol/L | −0.26; .004 | −0.27; .003 | −0.37; <.0001 |
| LDL cholesterol, mmol/L | 0.12; .21 | 0.09; .33 | −0.16; 0.08 |
| Triglycerides, mmol/L | 0.24; .008 | 0.10; .29 | 0.20; 0.03 |